One category of work that will remain limited and not widely visible to everyone is reviewer roles. These opportunities are more selective by design, so they will be hidden from most users and opened only to a smaller group of contributors. To keep access fair, we will be using a raffle-based selection process to choose reviewers from eligible participants.
Reviewer tasks are higher-value than standard microtasks, with payouts around $10 per job. As HumanLayer grows, these roles will become an important part of the platform for contributors who want access to more rewarding work. The goal is to make sure reviewer opportunities go to qualified users while still giving the wider community a fair chance to be selected.
The report is accurate per the latest CDC MMWR (March 2026). BA.3.2 ("Cicada"), an Omicron descendant first seen in South Africa late 2024, has ~70-75 spike mutations vs JN.1/LP.8.1 (current vaccine targets). Detected in NY + 24 other US states via wastewater/travelers/clinical samples; also 23 countries.
Impact: Shows potential immune escape in lab tests (reduced antibody response), but no evidence of more severe illness—symptoms remain mild/cold-like. Still very low prevalence (<1% sequenced cases). CDC/WHO monitoring; no surge in hospitalizations.
Stay informed via official sources. No major changes needed for most people right now.
The report is accurate per the latest CDC MMWR (March 2026). BA.3.2 ("Cicada"), an Omicron descendant first seen in South Africa late 2024, has ~70-75 spike mutations vs JN.1/LP.8.1 (current vaccine targets). Detected in NY + 24 other US states via wastewater/travelers/clinical samples; also 23 countries.
Impact: Shows potential immune escape in lab tests (reduced antibody response), but no evidence of more severe illness—symptoms remain mild/cold-like. Still very low prevalence (<1% sequenced cases). CDC/WHO monitoring; no surge in hospitalizations.
Stay informed via official sources. No major changes needed for most people right now.
After ANN winner reveal…
narrative locked 🔒
$CASO = America’s Favorite Pet 👑🇺🇸
This isn’t random pump
This is a potential runner 🚀
CA: BRPDQywftgYM4r4u5ZCFUxGDXTR2Q9gHSKTcaj5Spump
Early or exit liquidity, Choose
looks like @lalopenguin joined community 👀
dev behind $GROKPUTER
and builder of Grok Desktop
good to see the dev around.
CA
7qcXe4n73nkeMV8Sixx48etDWhpCTmt7C18xkeFRpump
I'm taking a stand for privacy.
Privacy is the missing key that will unlock new dimensions, expand opportunities, and finally bring the world onchain.
View my @aztecnetwork privacy glyph & create your own: https://t.co/xecWozhL3s
anon pls use my synq ref link so i can have more than 0 points and gmi 🥺
@multisynq synchronizers go brrrr 🚀
Join my network frens! #EverythingTogether https://t.co/Au7k24Iyuz
🔥Celebrate the launch of the Merak Testnet with us on Galxe! 🎉
❤️ Join the celebration:https://t.co/AZq4kD1Qrg
🎁 Don't miss out! Enter to win a Stars airdrop! (FCFS)🌟
#MerakTestnet#DeFi#Blockchain#Crypto#Airdrop#Move
1/ ✨ Ship a Move dApp without wrestling boilerplate
Dubhe Engine turns pnpm create dubhe
→ a compact app in minutes, leveraging the unique strength of the Move programming language.
Let’s dive in. 👇
🛠️ Dubhe: the MoveApp Creation Engine 10x #developers productivity
1/ Bootstrapping a new Move-based project is now one command: pnpm create dubhe
It scaffolds a #Move package with schema-based design and a NextJS frontend, no more manual config!